13FPulse
AD

ADMA ADMA BIOLOGICS INC

2026Q2 · CUSIP 000899104 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
317
Institutions that reported holding it to the SEC
Net decrease in holders
38
Last quarter 355 → now 317
How unusual is that
Bottom 20%
Stronger than only 3% of US stocks
What the filings say, in one paragraph

317 funds held ADMA at the end of 2026Q2, down 38 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $512M(YoY +8.0%), the P/E is 13.6x, return on equity is 41.4%. ADMA has had 13 buying rushes in its history, and the price moved +13.6% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2014Q3: holders=1 2014Q4: holders=13 2015Q1: holders=19 2015Q2: holders=24 2015Q3: holders=24 2015Q4: holders=25 2016Q1: holders=24 2016Q2: holders=27 2016Q3: holders=19 2016Q4: holders=18 2017Q1: holders=19 2017Q2: holders=19 2017Q3: holders=19 2017Q4: holders=23 2018Q1: holders=34 2018Q2: holders=54 2018Q3: holders=58 2018Q4: holders=52 2019Q1: holders=55 2019Q2: holders=66 2019Q3: holders=72 2019Q4: holders=74 2020Q1: holders=91 2020Q2: holders=95 2020Q3: holders=95 2020Q4: holders=95 2021Q1: holders=104 2021Q2: holders=89 2021Q3: holders=74 2021Q4: holders=88 2022Q1: holders=103 2022Q2: holders=113 2022Q3: holders=130 2022Q4: holders=161 2023Q1: holders=163 2023Q2: holders=179 2023Q3: holders=188 2023Q4: holders=184 2024Q1: holders=215 2024Q2: holders=254 2024Q3: holders=306 2024Q4: holders=323 2025Q1: holders=347 2025Q2: holders=370 2025Q3: holders=365 2025Q4: holders=355 2026Q1: holders=355 2026Q2: holders=317 -52 -26 +0 +26 +52 0195389 14Q316Q117Q319Q120Q322Q123Q325Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 13 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2025Q2 Top 20% -11.7% -9.3%
2025Q1 Top 10% -13.6% -23.6%
2024Q3 Top 5% -18.9% +3.2%
2024Q2 Top 5% +15.1% -8.4%
2024Q1 Top 10% +97.8% +106.7%
2023Q2 Top 20% -12.8% +21.6%
2022Q4 Top 20% +16.4% +18.2%
2022Q3 Top 10% +14.9% +29.7%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
162
Change in large funds
0
Total value they hold
$1.7B
Funds buying for the first time
52
Funds that sold out entirely
90
Price change that quarter
+13.5%
Funds holding puts (bearish)
5
Funds holding calls (bullish)
11

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
13.6
EPS (TTM)
$0.70
EPS YoY
-17.6%
Revenue (TTM)
$0.5B
Revenue YoY
+8.0%
Net margin
33.0%
ROE
41.4%
Debt ratio
40.3%
FCF (TTM)
$116M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.13 2021-12-31: EPS -0.07 2022-03-31: EPS -0.13 2022-06-30: EPS -0.07 2022-09-30: EPS -0.08 2022-12-31: EPS -0.05 2023-03-31: EPS -0.03 2023-06-30: EPS -0.03 2023-09-30: EPS 0.01 2023-12-31: EPS -0.08 2024-03-31: EPS 0.08 2024-06-30: EPS 0.13 2024-09-30: EPS 0.15 2024-12-31: EPS 0.45 2025-03-31: EPS 0.11 2025-06-30: EPS 0.14 2025-09-30: EPS 0.15 2025-12-31: EPS 0.20 2026-03-31: EPS 0.19 2026-06-30: EPS 0.16 0M 70M 139M $M -0.14 0.18 0.50 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 20 11 71 132 202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-39M8M56M 20162017201820192020202120222023202420252026
Latest quarter $56M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.